AS
ALNY icon

Aware Super’s Alnylam Pharmaceuticals ALNY Stock Holding History

Aware Super’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Buy
+5,473
New +$1.86M 0.03% 207
2025
Q3 		$6.23M Hold
13,665
– – 0.09% 161
2025
Q2 		$4.46M Hold
13,665
– – 0.07% 182
2025
Q1 		$3.69M Hold
13,665
– – 0.06% 185
2024
Q4 		$3.22M Buy
+13,665
New +$3.59M 0.05% 190
2023
Q4 		$2.33M Buy
+5,865
New +$999K 0.03% 206

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aware Super's ALNY Position: Q1 2026 in Review

Aware Super opened a new position in Alnylam Pharmaceuticals (ALNY) in Q1 2026: 5,473 shares worth $1.81M. The stake represents 0.03% of the portfolio and ranks #207 among its holdings. This is a return to the name: Aware Super previously reported a position in ALNY as recently as Q3 2025.

Aware Super first reported a position in ALNY in Q4 2023 and has held it in 6 quarters since. The position peaked at $6.23M in Q3 2025. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Aware Super held 5,473 shares of Alnylam Pharmaceuticals worth $1.81M as of Q1 2026.
  • Alnylam Pharmaceuticals was a new Aware Super position in Q1 2026.
  • Alnylam Pharmaceuticals made up 0.03% of Aware Super's portfolio in Q1 2026, its #207 holding.
  • Aware Super first reported a position in Alnylam Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
  • Aware Super's Alnylam Pharmaceuticals position peaked at $6.23M in Q3 2025.
  • 786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Aware Super's 13F filing for Q1 2026, filed 5 May 2026.